Workers Comp Prescription Drug Regulation – WCRI Releases Massive Report
A massive Workers Comp prescription drug regulation report was released by WCRI this week. Have you ever stopped to think how differently each state handles the complex world of prescription drugs?
By the way, see you next week at the 2026 WCRI Annual Conference in Boston if you are attending. Check out some of the conference posts here.
A fresh off-the-press report from WCRI sheds light on just bringing together the patchwork of laws across all 50 states and D.C. as of early 2026.
From medical marijuana rules to opioid monitoring, pharmacist roles to drug pricing, this snapshot reveals the many ways states are trying to balance patient care with safety. It’s a complex puzzle with many moving parts, and this inventory helps policymakers and stakeholders see the bigger picture all in one place.
In a rapidly changing landscape, understanding these differences matters—not just for regulators, but for anyone affected by workers’ compensation, including adjusters, risk managers, or anyone who deals with the complex topic of Workers Comp prescription regulation.
From the WCRI Website – my comments are in italics.
“States take very different approaches to regulating prescription drugs, especially controlled substances, and these efforts often involve multiple agencies,” said Ramona Tanabe, WCRI’s president and CEO. “This report gives policymakers and system stakeholders a clear overview of state strategies and directs them to the relevant regulations for more detail.”
The report, Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2026, highlights key prescription drug issues shaping state policy discussions, including:
- Medical marijuana regulations – this will be one of the hot topics for the next several years in prescriptions.
- Rules for limiting and monitoring opioid prescriptions
- Expanded roles for pharmacists in patient care
- Pharmacy benefit manager regulations
- Workers’ compensation drug formularies – great info
- Price regulations for pharmacy‑ and physician‑dispensed drugs
- Prescription drug monitoring programs – PDMPs exist in all 50 states and DC.
To develop the inventory, WCRI surveyed two agencies in each state and the District of Columbia. Because prescription drug regulations continue to evolve rapidly, the report provides a snapshot as of January 1, 2026. The report was authored by Karen Rothkin and Terence Cawley. – good job.
